Infection prevention and comparative effectiveness research.
作者信息
Perencevich Eli N, Lautenbach Ebbing
机构信息
Division of General Internal Medicine, University of Iowa, Carver College of Medicine, Iowa City, USA.
出版信息
JAMA. 2011 Apr 13;305(14):1482-3. doi: 10.1001/jama.2011.450.
PMID:21486981
Abstract
摘要
相似文献
1
Infection prevention and comparative effectiveness research.
JAMA. 2011 Apr 13;305(14):1482-3. doi: 10.1001/jama.2011.450.
2
Stopping HAIs at their source.
Nurse Pract. 2011 Sep;36(9):47-51. doi: 10.1097/01.NPR.0000403293.97339.64.
3
4
Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
JAMA. 2014 Oct 8;312(14):1395-6. doi: 10.1001/jama.2014.10142.
5
Recent initiatives to reduce the spread of meticillin-resistant Staphylococcus aureus.
Br J Hosp Med (Lond). 2009 Jul;70(7):399-401. doi: 10.12968/hmed.2009.70.7.43123.
6
Infection correction: hospital-acquired infections can be reduced significantly or even eliminated with sound prevention procedures.
State Legis. 2009 Apr;35(4):20-2.
7
Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update.
Infect Control Hosp Epidemiol. 2014 Jul;35(7):772-96. doi: 10.1086/676534.
8
Control of methicillin-resistant Staphylococcus aureus.
Infect Dis Clin North Am. 2011 Mar;25(1):155-79. doi: 10.1016/j.idc.2010.11.002.
9
Cluster randomized trials in comparative effectiveness research: randomizing hospitals to test methods for prevention of healthcare-associated infections.
Med Care. 2010 Jun;48(6 Suppl):S52-7. doi: 10.1097/MLR.0b013e3181dbebcf.
10
[Prevention and control of methicillin-resistant Staphylococcus aureus infections].
Soins. 1997 Nov(620):19-21.
引用本文的文献
1
Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.
Antimicrob Agents Chemother. 2012 Nov;56(11):5655-60. doi: 10.1128/AAC.01011-12. Epub 2012 Aug 20.
2
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.
Hepatology. 2012 Dec;56(6):2328-35. doi: 10.1002/hep.25947.
3
Bacterial infections in end-stage liver disease: current challenges and future directions.
Gut. 2012 Aug;61(8):1219-25. doi: 10.1136/gutjnl-2012-302339. Epub 2012 Jun 3.
4
Is it time for a blood pressure measurement "bundle"?
J Gen Intern Med. 2012 Jun;27(6):615-7. doi: 10.1007/s11606-012-2004-x.
Zotero 插件